Alpinion Medical Systems Launches E-CUBE 8, the New Ultrasound Diagnostic System

Food and Healthcare Press Releases Wednesday November 15, 2017 08:00
SEOUL, South Korea--15 Nov--PRNewswire/InfoQuest
  • E-CUBE 8 is the smartest solution for your daily practice.

One of South Korea's global medical device manufacturers, Alpinion Medical Systems introduced its new E-CUBE 8, the latest and last addition to the E-CUBE lineup. The E-CUBE 8 is a smart, reliable product that ensures high performance with outstanding image quality and multi-purpose usability, which improves clinicians' productivity.

The E-CUBE 8 uses a flagship model-grade platform to provide the improved resolution, contrast and uniformity of 2D images and with the addition of the Dual pulser, clear and accurate Doppler data can be displayed without compromising the 2D image quality.

The E-CUBE 8 also comes with the newly developed convex and phased array transducers of PowerView(TM) technology. The PowerView(TM) technology disperses heat generated and increases efficiency of ultrasonic waves.

The E-CUBE 8, with its ergonomic design and workflow, allows both the healthcare professionals and the patients have a positive individual experience. For such an experience, 21.5-inch full HD LED monitor and an intuitive UI design with a highly sensitive 10.4-inch capacitive touchscreen have been equipped. The control panel keys and the keyboard are arranged in the most efficient and intuitive manner to reduce unnecessary tasks and shorten the examination time.

The E-CUBE 8 uses high-end hardware with an SSD, enhancing stability in use and the fast boot time makes exam preparation quicker. The combination of compact exterior design and attached battery makes the E-CUBE 8 much easier to transport without space restrictions. Gel warmer with 3 steps of temperature control is optionally provided, helping to increase comfort for the patients.

This system offers features to generate enhanced visualization and intelligent analysis, making it a multi-purpose system that can be used in specialties that require ultrasound imaging. Its 3D/4D technology has been reinforced by Volume Advance(TM), more advanced features for handling volume data: Free Angle MSV, AnySlice(TM), and Volume Analysis. Clinical information in volume data can be delivered more accurately and in detail. Needle Vision(TM) Plus is also useful in showing the needle more clearly by adjusting the beam angle in three steps during ultrasound-guided procedures.

With those high-grade platforms and features, the E-CUBE 8 is expected to open a new era for mid-range ultrasound systems by offering new levels of efficiency and productivity.
Photo - https://photos.prnasia.com/prnh/20171019/1970216-1

Latest Press Release

Covaris Introduces the 96 oneTUBE-10 AFA Plate for Improved NGS Workflows

Today, Covaris Inc. announced the release of the 96 oneTUBE-10 AFA Plate, which enables scalable and simplified workflows by leveraging Covaris' gold standard focused-acoustic technology to meet rapidly increasing Next-Generation Sequencing (NGS) demands...

2018 Empire State Building Run-Up Lottery Registration Opens on November 14, 2017

Runners must enter by December 10 for a chance to participate in the 41st Annual Run-Up on Wednesday, February 7, 2018, at 8:00 p.m. Empire State Realty Trust, Inc. (NYSE: ESRT) today announced that lottery registration for the 2018 Empire State...

Alpinion Medical Systems Launches E-CUBE 8, the New Ultrasound Diagnostic System

One of South Korea's global medical device manufacturers, Alpinion Medical Systems introduced its new E-CUBE 8, the latest and last addition to the E-CUBE lineup. The E-CUBE 8 is a smart, reliable product that ensures high performance with outstanding...

Photo Release: The Royal Danish Embassy and Novo Nordisk Pharma (Thailand) Co., Ltd launch the Blueprint for Change address Diabetes challenge , aligned with national NCD targets

On the 5th November 2017, right after the WDD event at the Vachirabenjatas Park (Suan Rot Fai Park) . Mr.Uffe Wolffhechel, the ambassador of the Royal Danish Embassy, Thailand (right) together with Mr.Mihai Irimescu, General Manager of Novo Nordisk...

Stryker announces publication of the DAWN(TM) Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy. Currently, less than one in 10 patients suffering from...

Related Topics